Trading Window

September 29, 2026 To, To, The Listing Department The Listing Department BSE Limited, National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Bandra (East), Mumbai – 400001 Mumbai – 400051 Scrip code: 544889 Symbol: SYMBIOTEC Subject: Intimation of Closure of Trading Window pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 Dear Sir/Madam, Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, we wish to inform you that in terms of Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window for dealing in securities of the Company will remain closed for all Designated Person and their immediate relatives from Thursday, October 01, 2026 till 48 hours after the declaration of unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026. The same is being informed to the designated person and connected person in accordance with the Company’s Code of Conduct for Prohibition of Insider trading. The aforesaid information is also being made available on the Company's website i.e. https://investor.symbiotec.com/announcements Further, the date of meeting of the Board of Directors of the Company to consider and approve the unaudited Financial Results of the Company for the said period shall be informed in due course. Kindly take the same on record. Thanking you, For Symbiotec Pharmalab Limited Salil Jain Company Secretary & Compliance Officer Registered Office & Works: Symbiotec Pharmalab Limited (Formerly known as Symbiotec Pharmalab Pvt. Ltd.) 385/2, Pigdamber, Rau, Mhow, Indore - 453331, Madhya Pradesh, India Tel. No.: +91-731-6676405-406 Fax: +91-731-4201222, Email ID : symbiotec@symbiotec.com, Website : www.symbiotec.com CIN: U24232MP2002PLC015293